Cancer Genetics, AstraZeneca CAMCAR Team on Dx Testing in Central America and Caribbean | GenomeWeb

NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has signed an agreement with AstraZeneca CAMCAR, a division of drug giant AstraZeneca, to provide biomarker-based cancer diagnostic testing in Central America and the Caribbean.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.